Exploring sociodemographic and economic factors that promote adverse drug reactions reporting by patients

Adverse drug reactions (ADRs) are recognized as a leading cause of morbidity and mortality, and an important cost factor to health systems in different countries [1]. The economic impact of ADRs is complex and multifactorial [2]. It seldom leads to hospitalization of patients, with corresponding pharmacotherapy problems and increasing costs during their hospital stay [3]. ADRs are among the top ten causes of death in some countries [4]. In the European Union (EU) alone, it is estimated that the total costs are high as €79 billion, causing over 197,000 deaths annually [3].

Source: Health Policy - November 1, 2017 Category: Health Management Authors: Pedro In ácio, João José Gomes, Marja Airaksinen, Afonso Cavaco Source Type: research